Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic #946; Cell Function: Potential Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|2|2|129-139

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.2, Iss.2, 2002-07, pp. : 129-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens

By Papanastasiou Anastasios D   Chatzantoni Kokona   Mouzaki Athanasia  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 10, 2008-10 ,pp. : 1255-1265

Informa Healthcare

Access to resources Recommend Favorite

Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 714-745

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modification of Transcription Factors: Mechanisms and Potential Therapeutic Interventions

By  

Current Molecular Pharmacology, Vol. 6, Iss. 3, 2013-11 ,pp. : 173-182

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of Nuclear Co-repressor RIP140: A Therapeutic Target for Metabolic Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 386-392

Bentham Science Publishers

Access to resources Recommend Favorite